Viagra, Cialis, & Levitra: Board of Patent Appeals Affirms Rejection of Pfizer’s Broad Patent over ED Treatment February 15, 2010Patentanticipation, Enablement, obviousness, paid, USPTO DirectorDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post. Login